NYSE:ZTS - Zoetis Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $161.14
  • Forecasted Upside: -0.20 %
  • Number of Analysts: 18
  • Breakdown:
  • 0 Sell Ratings
  • 9 Hold Ratings
  • 8 Buy Ratings
  • 1 Strong Buy Ratings
$161.47
▲ +1.28 (0.80%)
1 month | 3 months | 12 months
Get New Zoetis Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ZTS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ZTS

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$161.14
▼ -0.20% Downside Potential
This price target is based on 18 analysts offering 12 month price targets for Zoetis in the last 3 months. The average price target is $161.14, with a high forecast of $191.00 and a low forecast of $126.00. The average price target represents a -0.20% upside from the last price of $161.47.
Buy
The current consensus among 18 contributing investment analysts is to buy stock in Zoetis. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 7 buy ratings
  • 6 hold ratings
  • 0 sell ratings
6/7/2019
  • 0 strong buy ratings
  • 8 buy ratings
  • 6 hold ratings
  • 0 sell ratings
9/5/2019
  • 0 strong buy ratings
  • 8 buy ratings
  • 6 hold ratings
  • 0 sell ratings
12/4/2019
  • 1 strong buy ratings
  • 8 buy ratings
  • 7 hold ratings
  • 0 sell ratings
3/3/2020
  • 1 strong buy ratings
  • 8 buy ratings
  • 7 hold ratings
  • 0 sell ratings
6/1/2020
  • 1 strong buy ratings
  • 7 buy ratings
  • 9 hold ratings
  • 0 sell ratings
8/30/2020
  • 1 strong buy ratings
  • 8 buy ratings
  • 9 hold ratings
  • 0 sell ratings
10/29/2020
  • 1 strong buy ratings
  • 8 buy ratings
  • 9 hold ratings
  • 0 sell ratings
11/28/2020

Latest Recommendations

  • 1 strong buy ratings
  • 8 buy ratings
  • 9 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/13/2020Morgan StanleyBoost Price TargetEqual Weight$167.00 ➝ $174.00Low
i
11/12/2020TruistBoost Price Target$160.00 ➝ $170.00Low
i
11/6/2020BarclaysBoost Price TargetOverweight$175.00 ➝ $189.00Medium
i
9/21/2020Atlantic SecuritiesInitiated CoverageOverweight$191.00Low
i
8/20/2020Morgan StanleyBoost Price TargetNeutral ➝ Equal Weight$125.00 ➝ $167.00Low
i
8/14/2020Edward JonesUpgradeHold ➝ BuyLow
i
8/12/2020G.ResearchDowngradeBuy ➝ HoldLow
i
Rating by K. Kedra at G.Research, Llc
8/12/2020GabelliDowngradeBuy ➝ HoldLow
i
8/10/2020Truist FinancialBoost Price TargetNeutral ➝ Hold$112.00 ➝ $160.00Low
i
8/10/2020CitigroupBoost Price TargetNeutral$146.00 ➝ $160.00Low
i
8/7/2020Stifel NicolausBoost Price TargetTop Pick ➝ Buy$155.00 ➝ $170.00Medium
i
7/30/2020CitigroupBoost Price TargetNeutral$131.00 ➝ $146.00Medium
i
7/20/2020Bank of AmericaBoost Price TargetNeutral$135.00 ➝ $150.00Medium
i
Rating by Michael Ryskin at Bank of America Co.
6/3/2020ArgusReiterated RatingBuyLow
i
5/27/2020Jefferies Financial GroupInitiated CoverageBuy$152.00High
i
5/18/2020Credit Suisse GroupReiterated RatingBuy$147.00High
i
5/8/2020UBS GroupLower Price TargetNeutral$146.00 ➝ $126.00Low
i
5/8/2020CitigroupLower Price TargetNeutral$139.00 ➝ $131.00Low
i
5/7/2020BarclaysBoost Price TargetOverweight$129.00 ➝ $140.00Medium
i
4/2/2020Morgan StanleyLower Price TargetEqual Weight$148.00 ➝ $125.00High
i
3/31/2020G.ResearchUpgradeHold ➝ BuyHigh
i
Rating by K. Kedra at G.Research, Llc
2/28/2020The Goldman Sachs GroupReiterated RatingBuy$162.00High
i
Rating by Nathan Rich at The Goldman Sachs Group, Inc.
2/19/2020UBS GroupBoost Price TargetNeutral$126.00 ➝ $146.00Low
i
2/14/2020Morgan StanleyBoost Price TargetEqual Weight$136.00 ➝ $148.00Low
i
Rating by David Risinger at Morgan Stanley
2/14/2020SunTrust BanksReiterated RatingHold$145.00Low
i
2/13/2020CfraUpgradeBuy ➝ Strong-Buy$147.00 ➝ $160.00Low
i
2/12/2020Bank of AmericaReiterated RatingHold$145.00Medium
i
Rating by Michael Ryskin at Bank of America Co.
1/9/2020Raymond JamesInitiated CoverageMarket PerformLow
i
12/5/2019Bank of AmericaReiterated RatingHold$125.00Low
i
10/11/2019Credit Suisse GroupSet Price TargetBuy$138.00Low
i
Rating by Erin Wright at Credit Suisse Group AG
9/30/2019Morgan StanleyBoost Price TargetHold ➝ Equal Weight$100.00 ➝ $136.00Low
i
9/13/2019Stifel NicolausSet Price TargetBuy$140.00Medium
i
Rating by Jonathan Block at Stifel Nicolaus
9/11/2019Credit Suisse GroupReiterated RatingBuy$130.00High
i
9/9/2019The Goldman Sachs GroupInitiated CoverageConviction-Buy$145.00Medium
i
9/4/2019ArgusSet Price TargetBuy$140.00Low
i
Rating by Jasper Hellweg at Argus
8/13/2019SunTrust BanksBoost Price TargetHold$120.00 ➝ $130.00Low
i
8/7/2019Craig HallumBoost Price TargetBuy$132.00 ➝ $138.00Low
i
8/7/2019BarclaysBoost Price TargetOverweight$120.00 ➝ $135.00Low
i
Rating by Balaji Prasad at Barclays PLC
7/22/2019Stifel NicolausBoost Price TargetBuy$110.00 ➝ $130.00Medium
i
7/1/2019Bank of AmericaDowngradeBuy ➝ Neutral$111.00 ➝ $120.00Low
i
6/25/2019Craig HallumBoost Price TargetBuy$114.00 ➝ $132.00Low
i
6/12/2019Cantor FitzgeraldReiterated RatingOverweight$116.00 ➝ $130.00Low
i
6/11/2019BarclaysInitiated CoverageOverweight ➝ Overweight$120.00Low
i
5/23/2019GuggenheimInitiated CoverageBuy ➝ Buy$114.00Low
i
5/9/2019BMO Capital MarketsBoost Price TargetMarket Perform$101.00 ➝ $105.00Low
i
5/2/2019GabelliDowngradeBuy ➝ Hold$108.00Low
i
Rating by K. Kedra at Gabelli
4/2/2019Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$102.00 ➝ $112.00Low
i
3/20/2019UBS GroupInitiated CoverageNeutralLow
i
3/19/2019SunTrust BanksInitiated CoverageHold ➝ Hold$100.00Low
i
3/4/2019Stifel NicolausUpgradeHold ➝ Buy$97.00 ➝ $110.00Medium
i
2/25/2019BMO Capital MarketsBoost Price TargetMarket Perform ➝ Market Perform$93.00 ➝ $101.00Low
i
1/23/2019UBS GroupInitiated CoverageNeutral ➝ Neutral$86.00Low
i
11/13/2018ArgusSet Price TargetBuy$105.00Medium
i
Rating by Jasper Hellweg at Argus
11/12/2018BMO Capital MarketsBoost Price TargetMarket Perform ➝ Neutral$93.00Low
i
11/11/2018BMO Capital MarketsReiterated RatingHoldLow
i
11/2/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$100.00 ➝ $101.00Low
i
Rating by Chris Schott at JPMorgan Chase & Co.
11/2/2018Morgan StanleySet Price TargetHold$100.00Low
i
Rating by David Risinger at Morgan Stanley
10/17/2018Cantor FitzgeraldReiterated RatingOverweight$98.00 ➝ $105.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
10/15/2018JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$100.00Medium
i
10/1/2018Cantor FitzgeraldReiterated RatingBuy$98.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
8/21/2018Stifel NicolausDowngradeBuy ➝ Hold$95.00High
i
8/14/2018ArgusBoost Price TargetBuy ➝ Buy$90.00 ➝ $103.00Low
i
8/3/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$86.00 ➝ $95.00Low
i
8/3/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Hold$87.00 ➝ $92.00Low
i
Rating by David Risinger at Morgan Stanley
8/2/2018BMO Capital MarketsReiterated RatingHold$82.00High
i
Rating by Alex Arfaei at BMO Capital Markets
8/2/2018Cantor FitzgeraldSet Price TargetBuy$98.00High
i
Rating by Louise Chen at Cantor Fitzgerald
7/30/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$97.00 ➝ $100.00Low
i
7/27/2018Cantor FitzgeraldSet Price TargetBuy$98.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
7/13/2018Jefferies Financial GroupSet Price TargetBuy$96.00Medium
i
Rating by Ian Hilliker at Jefferies Financial Group Inc.
6/6/2018Cantor FitzgeraldSet Price TargetBuy$98.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
5/16/2018BMO Capital MarketsReiterated RatingHold$80.00Low
i
Rating by Alex Arfaei at BMO Capital Markets
5/16/2018Cantor FitzgeraldReiterated RatingBuy$98.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
5/1/2018Cantor FitzgeraldSet Price TargetBuy$90.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
4/25/2018Craig HallumReiterated RatingBuy$87.00 ➝ $94.00Low
i
4/24/2018Cantor FitzgeraldSet Price TargetBuy$90.00Medium
i
Rating by Louise Chen at Cantor Fitzgerald
4/19/2018Hilliard LyonsDowngradeNeutralLow
i
4/19/2018CitigroupReiterated RatingBuy ➝ Buy$85.00 ➝ $98.00Low
i
Rating by Liav Abraham at Citigroup Inc.
4/13/2018Jefferies Financial GroupReiterated RatingBuy$96.00Low
i
Rating by Ian Hilliker at Jefferies Financial Group Inc.
4/5/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$83.00 ➝ $89.00Low
i
3/19/2018Morgan StanleyDowngradeOverweight ➝ Equal Weight$70.00Low
i
Rating by David Risinger at Morgan Stanley
2/26/2018Jefferies Financial GroupSet Price TargetBuy$97.00Low
i
Rating by Ian Hilliker at Jefferies Financial Group Inc.
2/17/2018BarclaysSet Price TargetHold$77.00Medium
i
Rating by Douglas Tsao at Barclays PLC
2/16/2018Deutsche Bank AktiengesellschaftBoost Price TargetHold ➝ Hold$76.00 ➝ $78.00Low
i
2/16/2018Piper Jaffray CompaniesSet Price TargetBuy$88.00Low
i
Rating by Brett Wong at Piper Jaffray Companies
2/16/2018Stifel NicolausReiterated RatingBuy ➝ Buy$84.00 ➝ $86.00Medium
i
2/16/2018Bank of AmericaBoost Price TargetBuy$80.00 ➝ $87.00Medium
i
2/15/2018Cantor FitzgeraldSet Price TargetBuy$90.00Medium
i
Rating by Louise Chen at Cantor Fitzgerald
2/15/2018BMO Capital MarketsSet Price TargetHold$78.00Medium
i
Rating by Alex Arfaei at BMO Capital Markets
2/15/2018CowenSet Price TargetBuy$85.00Medium
i
Rating by Steve Scala at Cowen Inc
1/22/2018BMO Capital MarketsSet Price TargetHold$78.00Low
i
Rating by Alex Arfaei at BMO Capital Markets
1/18/2018Piper Jaffray CompaniesReiterated RatingBuy$86.00Low
i
Rating by Brett Wong at Piper Jaffray Companies
1/16/2018Jefferies Financial GroupReiterated RatingBuy$89.00High
i
1/11/2018Cantor FitzgeraldSet Price TargetBuy$85.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
1/9/2018BMO Capital MarketsBoost Price TargetPositive ➝ Market Perform$78.00Medium
i
Rating by Alex Arfaei at BMO Capital Markets
1/8/2018BMO Capital MarketsReiterated RatingHoldLow
i
Rating by Alex Arfaei at BMO Capital Markets
1/4/2018CitigroupUpgradeNeutral ➝ Buy$85.00Low
i
Rating by Liav Abraham at Citigroup Inc.
1/2/2018Craig HallumReiterated RatingBuy$77.00 ➝ $85.00Low
i
1/2/2018Cantor FitzgeraldSet Price TargetBuy$85.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
12/26/2017Cantor FitzgeraldSet Price TargetBuy$85.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
12/12/2017Cantor FitzgeraldSet Price TargetBuy$80.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
11/29/2017Morgan StanleyUpgradeEqual Weight ➝ Overweight$80.00Low
i
11/24/2017UBS GroupReiterated RatingBuy ➝ NeutralN/A
i
11/17/2017CowenSet Price TargetBuy$70.00 ➝ $80.00N/A
i
Rating by Steve Scala at Cowen Inc
11/10/2017Jefferies Financial GroupReiterated RatingBuyN/A
i
11/3/2017BMO Capital MarketsBoost Price TargetMarket Perform$65.00 ➝ $70.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
11/3/2017Morgan StanleyBoost Price TargetEqual Weight$61.00 ➝ $70.00N/A
i
11/2/2017BMO Capital MarketsReiterated RatingHold$65.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
10/31/2017Cantor FitzgeraldSet Price TargetBuy$75.00N/A
i
Rating by Louise Chen at Cantor Fitzgerald
10/25/2017BMO Capital MarketsSet Price TargetHold$65.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
10/24/2017Cantor FitzgeraldReiterated RatingBuy$75.00N/A
i
Rating by Louise Chen at Cantor Fitzgerald
10/24/2017Stifel NicolausReiterated RatingBuy$65.00N/A
i
9/26/2017Cantor FitzgeraldReiterated RatingBuy$75.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
9/6/2017Cantor FitzgeraldReiterated RatingBuy$75.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
9/1/2017Stifel NicolausReiterated RatingBuy$65.00Low
i
8/25/2017Piper Jaffray CompaniesSet Price TargetBuy$73.00Low
i
8/24/2017CowenSet Price TargetBuy$70.00Low
i
Rating by Steve Scala at Cowen Inc
8/14/2017Cantor FitzgeraldSet Price TargetBuy$75.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
8/7/2017The Goldman Sachs GroupReiterated RatingNeutral ➝ Neutral$62.00Low
i
7/25/2017Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$65.00High
i
7/21/2017Stifel NicolausReiterated RatingBuy$65.00Low
i
7/17/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$62.00 ➝ $65.00Low
i
7/17/2017CowenSet Price TargetBuy$70.00Low
i
Rating by Steve Scala at Cowen Inc
7/11/2017CowenSet Price TargetBuy$60.00Low
i
6/20/2017Hilliard LyonsInitiated CoverageBuy$77.00Low
i
6/16/2017Cantor FitzgeraldInitiated CoverageOverweight ➝ Overweight$75.00Low
i
6/13/2017BMO Capital MarketsDowngradeOutperform ➝ Market Perform$64.00 ➝ $65.00Low
i
Rating by Alex Arfaei at BMO Capital Markets
5/30/2017ArgusReiterated RatingBuy$60.00 ➝ $69.00Low
i
5/26/2017CL KingInitiated CoverageBuy ➝ Buy$71.00Low
i
5/24/2017Credit Suisse GroupBoost Price TargetOutperform$61.00 ➝ $67.00Low
i
5/9/2017Jefferies Financial GroupBoost Price TargetBuy$65.00 ➝ $70.00Low
i
5/4/2017BMO Capital MarketsReiterated RatingBuy$60.00High
i
Rating by Alex Arfaei at BMO Capital Markets
3/15/2017Craig HallumInitiated CoverageBuy$65.00Low
i
2/19/2017BMO Capital MarketsReiterated RatingOutperform$60.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
2/16/2017GuggenheimBoost Price TargetBuy$60.00 ➝ $65.00N/A
i
Rating by Louise Chen at Guggenheim
2/16/2017Off Wall StreetReiterated RatingStrong Sell$35.00N/A
i
2/8/2017BMO Capital MarketsReiterated RatingBuy$60.00N/A
i
Rating by Alex Arfaei at BMO Capital Markets
1/20/2017Jefferies Financial GroupBoost Price TargetBuy$62.00 ➝ $64.00N/A
i
12/23/2016GuggenheimReiterated RatingBuy$60.00N/A
i
12/23/2016BMO Capital MarketsReiterated RatingOutperform$59.00N/A
i
12/20/2016Deutsche Bank AktiengesellschaftInitiated CoverageBuy$62.00N/A
i
12/20/2016Jefferies Financial GroupReiterated RatingBuy$62.00N/A
i
12/15/2016Piper Jaffray CompaniesReiterated RatingOverweight$61.00N/A
i
12/15/2016CowenUpgradeMarket Perform ➝ Outperform$50.00 ➝ $60.00N/A
i
11/3/2016JPMorgan Chase & Co.Reiterated RatingHold$53.00N/A
i
10/16/2016Jefferies Financial GroupReiterated RatingBuy$63.00N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
10/12/2016Stifel NicolausReiterated RatingBuy$58.00N/A
i
Rating by Jonathan Block at Stifel Nicolaus
9/29/2016Bank of AmericaInitiated CoverageBuy$60.00N/A
i
9/14/2016Jefferies Financial GroupReiterated RatingBuy$60.00N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
9/9/2016ArgusBoost Price TargetBelow Average$54.00 ➝ $58.00N/A
i
9/7/2016Credit Suisse GroupReiterated RatingFocus List$60.00N/A
i
Rating by Erin Wilson at Credit Suisse Group AG
8/23/2016Credit Suisse GroupReiterated RatingOutperform$60.00N/A
i
Rating by Erin Wilson at Credit Suisse Group AG
8/23/2016Jefferies Financial GroupReiterated RatingBuy$60.00N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
8/22/2016GuggenheimReiterated RatingPositive$60.00N/A
i
Rating by Louise Chen at Guggenheim
8/4/2016Jefferies Financial GroupBoost Price TargetBuy$58.00 ➝ $60.00N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
8/4/2016CitigroupBoost Price TargetNeutral$50.00 ➝ $53.00N/A
i
Rating by Liav Abraham at Citigroup Inc.
8/4/2016BarclaysBoost Price TargetEqual Weight$45.00 ➝ $49.00N/A
i
7/18/2016GuggenheimReiterated RatingBuy$60.00N/A
i
Rating by Louise Chen at Guggenheim
6/14/2016Jefferies Financial GroupReiterated RatingBuy$57.00 ➝ $58.00N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
6/10/2016CitigroupDowngradeBuy ➝ Neutral$46.00 ➝ $50.00N/A
i
5/31/2016Stifel NicolausInitiated CoverageBuy$58.00N/A
i
5/22/2016Credit Suisse GroupReiterated RatingBuyN/A
i
Rating by Erin Wilson at Credit Suisse Group AG
5/8/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
5/6/2016The Goldman Sachs GroupDowngradeNeutral ➝ Sell$46.00 ➝ $48.00N/A
i
5/4/2016GuggenheimReiterated RatingBuy$60.00N/A
i
Rating by Louise Chen at Guggenheim
3/15/2016Jefferies Financial GroupBoost Price TargetBuy$50.00 ➝ $53.00N/A
i
2/22/2016Jefferies Financial GroupLower Price TargetBuy$50.00N/A
i
2/17/2016Piper Jaffray CompaniesReiterated RatingOverweight$58.00 ➝ $53.00N/A
i
Rating by Kevin Ellich at Piper Jaffray Companies
2/17/2016The Goldman Sachs GroupLower Price TargetNeutral$47.00 ➝ $43.00N/A
i
2/17/2016CitigroupLower Price TargetBuy$52.00 ➝ $46.00N/A
i
2/3/2016Credit Suisse GroupInitiated CoverageOutperform$58.00N/A
i
1/14/2016Jefferies Financial GroupLower Price Target$54.00N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
1/13/2016GuggenheimReiterated RatingBuy$60.00N/A
i
Rating by Louise Chen at Guggenheim
1/8/2016Cleveland ResearchInitiated CoverageBuyN/A
i
1/3/2016ArgusReiterated RatingBuyN/A
i
Rating by John Eade at Argus
12/28/2015ArgusReiterated RatingBuy$57.00N/A
i
Rating by John Eade at Argus
12/16/2015Piper Jaffray CompaniesReiterated RatingBuy$58.00N/A
i
Rating by Kevin Ellich at Piper Jaffray Companies
12/7/2015Jefferies Financial GroupBoost Price TargetBuy$56.00N/A
i
Rating by Jeffrey Holford at Jefferies Financial Group Inc.
(Data available from 11/28/2015 forward)
Zoetis logo
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; Dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Read More

Today's Range

Now: $161.47
$160.29
$162.19

50 Day Range

MA: $164.04
$158.55
$174.35

52 Week Range

Now: $161.47
$90.14
$176.64

Volume

853,298 shs

Average Volume

2,058,621 shs

Market Capitalization

$76.74 billion

P/E Ratio

47.91

Dividend Yield

0.50%

Beta

0.71